1, Wuxi pharmatech
In the CDMO list, Wuxi PharmaTech ranks first, which makes most CDMO enterprises lag behind with its strong core competitiveness. With the expansion of CDMO production capacity in 2020, A+H will increase, which will further help its rapid development and lay the foundation for long-term business growth. And with the gradual transfer of overseas production capacity to China, it is expected to usher in the golden period of development again.
2. Yao Ming Biology
Yao Ming Bio won the second place in the CDMO list, but its score of 20 19 was not inferior to that of No.1 "Wuxi Kant". As a carrier of macromolecular R&D and production outsourcing services, Yao Ming Bio is the world's leading open and integrated biopharmaceutical capability and technology empowerment platform company.
The company has a comprehensive business coverage, complete and excellent technical and management team, a distinctive technical platform, and a leading edge in research and development, which can significantly improve the research and development efficiency for pharmaceutical enterprises and has high customer stickiness.
3. Tiger medicine
Tiger medicine won the third place in the CDMO list this time. The full name of TAG Pharmaceutical Co., Ltd. (stock code: 300347) is a contract research institution dedicated to providing professional services for the whole process of clinical trials in pharmaceutical product research and development, and is committed to reducing R&D risks for customers, saving R&D funds and promoting the process of product marketization.